Press Releases
-
June 25, 2009
Selenium intake may worsen prostate cancer in some, study reportsIn prostate cancer patients with a certain genetic variant, a high level of selenium in the blood was associated with a two-fold greater risk of poorer outcomes than men with the lowest amounts of selenium. read more
-
June 24, 2009
Study pinpoints novel cancer gene and biomarkerResearchers working in genomics and molecular biology have demonstrated that a surplus of a gene known as GOLPH3 can spur cancer cell growth. read more
-
June 17, 2009
Financial coaches help cancer patients at Dana-FarberFor cancer patients, the stresses of managing everyday expenses and care-related costs can be particularly trying, especially in this tough economy. A new service at Dana-Farber pairs patients with financial experts to help them with budgeting issues. read more
-
June 9, 2009
Study identifies benefit of donor stem cell transplantation for adults with acute myeloid leukemiaAn analysis of two dozen clinical studies finds most adults with poor-risk and intermediate-risk acute myeloid leukemia benefit from allogeneic stem cell transplants. read more
-
June 8, 2009
After a century, link between chromosomal instability and centrosome defects in cancer cells is unraveledIn a new study, Dana-Farber scientists disprove a century-old theory about why cancer cells often have too many or too few chromosomes, and show that the actual reason may hold the key to a novel approach to cancer therapy. read more
-
May 29, 2009
New blood test reduces false-positives in prostate cancer screeningA new blood test increases the accuracy of prostate cancer diagnosis and could eliminate tens of thousands of unneeded prostate biopsies annually, Dana-Farber researchers report. read more
-
May 29, 2009
Chemotherapy combo outcomes differ based on age of colon cancer patientsA combination of chemotherapies for colon cancer decreases recurrence for patients under 70, but not for those who are older, according to Mayo Clinic and Dana-Farber scientists. read more
-
May 29, 2009
One in ten advanced colon cancer patients worry about prescription drug costsThe vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs, according to a study led by Dana-Farber researchers. read more
-
May 21, 2009
Is your sunscreen keeping you sun safe?Sunscreen is an important first line of protection, but can lose effectiveness over time, warn Dana-Farber's melanoma experts. read more
-
May 20, 2009
Scientists create custom three-dimensional structures with "DNA origami"By combining the art of origami with the science of nanotechnology, researchers have created DNA shapes that could be used to deliver drugs directly to cancer cells. read more
-
May 14, 2009
Standard chemo proves best for older women with early breast cancerStandard chemotherapy is more effective than oral drug capecitabine following surgery in older women with early breast cancer, according to a study co-led by Dana-Farber researchers. read more
-
May 8, 2009
Ambassador Brinker presents keynote address at Dana-Farber dinnerFounding chair of Susan G. Komen for the Cure® notes Dana-Farber's presence "on the cutting edge of breast cancer." read more
-
April 27, 2009
Dana-Farber opens advanced cancer imaging centerLurie Family Imaging Center will help researchers study tumors at the molecular level without the need for biopsy, using specially designed MRI, CT, PET, ultrasound and optical scanners. read more
-
April 19, 2009
microRNA discovered to play role in DNA repairThe discovery that microRNA helps control the repair of damaged DNA within cells may lead to new tests for determining a tumor's aggressiveness and likely response to therapies. read more
-
March 31, 2009
Dana-Farber Cancer Institute receives CEO Cancer Gold StandardTM accreditationCertification recognizes commitment to health of Dana-Farber's employees and family members by certifying its efforts to meet high standard of cancer prevention, screening, and care guidelines. read more
-
March 26, 2009
Dana-Farber Cancer Institute president comments on Senators Kennedy and Hutchison's cancer legislationEdward J. Benz, Jr., MD, offers his thoughts on the introduction of the 21st Century Cancer Access to Life-Saving Early detection, Research and Treatment (ALERT) Act. read more
-
March 18, 2009
Study finds link between religious coping and use of aggressive treatment as advanced cancer patients near deathDana-Farber researchers find that patients with deeper religious beliefs often prefer and receive aggressive end-of-life treatment. read more
-
March 11, 2009
Blood type study sheds light on biology of pancreatic cancerDana-Farber researchers find a link between blood type and the risk of developing pancreatic cancer. read more
-
March 9, 2009
Doctor-patient conversations at end of life associated with lower medical expenses, study findsDana-Farber researchers find end-of-life conversations between doctors and patients could lower national healthcare expenditures by millions of dollars a year. read more
-
March 6, 2009
Survey: Few physicians support private banking of umbilical cord bloodDana-Farber researchers find that physicians surveyed advise against private blood banking of umbilical cord blood unless another family member is at risk for a blood disease. read more
-
February 23, 2009
Patient knowledge of health information influences cancer treatmentColorectal cancer patients who seek out health information online and in news media are more likely to be aware of, and receive, the latest treatments, researchers find. read more
-
February 22, 2009
Scientists identify human monoclonal antibodies effective against bird and seasonal flu virusesResearchers report that these antibodies have the potential for use in combination with other treatments to prevent or treat certain types of avian and seasonal flu. read more
-
February 10, 2009
Clinicians using electronic prescribing override most medication safety alertsA new study suggests most clinicians find computer-based drug interaction alerts more of an annoyance than a valuable tool, and suggests improvements to enhance patient safety. read more
-
February 4, 2009
What’s in a name? For patients, a piece of historyWhen Katie Hayes went to her doctor’s appointment one recent morning, she didn’t know she was going to be immortalized in steel. She and other Jimmy Fund Clinic and Dana-Farber patients watched as an ironworker spray-painted their names onto one of the beams of the Yawkey Center for Cancer Care. read more
-
January 27, 2009
Dana-Farber classes help smokers quitDana-Farber is offering inexpensive weekly classes with flexible schedules to help smokers fulfill their New Year's resolutions to quit smoking. read more
-
January 9, 2009
Staying healthy doesn't have to break the bankLooking for ways to stay healthy despite the tough economic climate? Dana-Farber experts offer free and easy tips to maintain good health and reduce cancer risks. read more
-
January 6, 2009
Studies offer guide as protein interaction mapping comes of ageDana-Farber researchers suggest guidelines and provide tools to minimize inconsistencies in collecting and sharing data on interactions between cell proteins. read more
